3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Unknown
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
12
Neoplasms
10
Multiple Myeloma
8
Prostatic Neoplasms
6
Neoplasm Metastasis
5
Giant Cell Tumor of Bone
5
Fractures, Bone
4
Recurrence
3
Osteoporosis
3
Bone Neoplasms
3
Bone Diseases, Metabolic
3
Spinal Cord Compression
2
Smoldering Multiple Myeloma
2
Parathyroid Neoplasms
2
Lymphoma
2
Kidney Neoplasms
2
Giant Cell Tumors
2
Carcinoma, Non-Small-Cell Lung
2
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Thyroid Neoplasms
1
Paraproteinemias
1
Pancreatic Neoplasms
1
Osteosarcoma
1
Neoplastic Processes
1
Neoplasms, Plasma Cell
1
Multiple Endocrine Neoplasia Type 1
1
Melanoma
1
Mastocytosis, Systemic
1
Lymphoma, Non-Hodgkin
1
Interventions
Surgical Procedures, Operative
1
Denosumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Bone Cysts, Aneurysmal
×
Denosumab
×
Clear all
NCT03415477
2018-01-30
Deno-ABC
Peking University People's Hospital
Phase 1/2
Completed
6 enrolled